The US Food and Drug Administration predicts that by 2025, approvals for innovative cell and gene therapies will increase by up to 900 per cent, significantly helping more people and families with illnesses such as neurodegenerative disease and cancer. ISCT plays an important role in the clinical translation of these life-saving therapies and welcomes this encouraging statement as the cell and gene therapy field continues to expand. Read more...
#News